How will generative AI change clinicians' roles?

The latest stories trending on MedCity News.

MedCity News' daily newsletter will be paused on Monday, September 4, in observance of Labor Day. It will resume on Tuesday, September 5.

Editor's Pick

Top Story How Will Generative AI Change the Role of Clinicians In the Next 10 Years? A new report predicted that generative AI tools will increasingly streamline many aspects of a clinician's day in the next five to 10 years — and that this is particularly true for tools that can automate diagnoses and respond to patients' questions. Sponsored Content Next-Generation Proteomics Presented by Quantum-Si Quantum-Si's Platinum benchtop protein sequencer offers a simpler, more economical alternative to mass spectrometry. Learn More>>

Featured News

Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women's Health A webinar sponsored by AVIA Health and SeamlessMD will discuss the latest trends in remote monitoring and how to extend these benefits beyond chronic conditions all while using fewer staff resources. How Hospitals Can Meet New Requirements for Workplace Violence Prevention When violence in general—including gun violence—goes unchecked in any hospital setting, the physical and psychological impact can be severe, lasting and even devastating. Beyond injuries and tragic loss of life, the fallout from unchecked violence creates worker anxiety, loss of productivity and workdays, and significant legal and reputational losses. 5 Foundational Capabilities Needed for Implementing a Value-Based Care Program Apprehension among practices and providers is understandable, given the complexity and variance of VBC contracts. However, instead of feeling overwhelmed and burdened by VBC, practices can slowly embrace these concepts by leveraging the many tools they already have in place or that exist in the healthcare ecosystem. Taming the Healthcare Data Beast: Conquering Complexity for Better Care By following these foundational data best practices, healthcare organizations will harness the power of their data to provide superior patient care while safeguarding patient privacy and compliance. Twice Rejected Diabetes Drug/Device Product Gets New Chance at Startup i2O Intarcia Therapeutics' GLP-1 agonist product candidate for type 2 diabetes now belongs to i2O Therapeutics, which will make the treatment's case for approval at an upcoming FDA advisory committee meeting. The startup's $46 million Series A financing is one of several recently announced funding rounds. Report: About Half of MA Beneficiaries Leave Their Plan After 5 Years After five years of enrolling in a Medicare Advantage plan, 48.3% of non-dually enrolled beneficiaries left their contract and 53.4% of dually enrolled beneficiaries did, a new study found. US Prescription Drug Costs More Than Double Those in Canada Increasingly, patients in the U.S. look to Canada for more affordable prescription options since the Canadian government regulates drug costs. Some companies have noticed and are beginning to capitalize on the demand.

Resources

MedCity Pivot Podcast: A Conversation With Unlearn.AI CEO About Clinical Trials The founder and CEO of Unlearn.AI seeks to make clinical trials more efficient and less costly by leveraging its Digital Twin technology. If the company is successful, drugs could potentially be brought to market sooner and in a cost effective manner. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe